Select Language:
Scientists have found that weight-loss surgery may significantly improve the quality of life for people dealing with obesity and chronic kidney disease. New studies suggest these procedures can lower the risk of kidney failure, decrease the likelihood of heart attacks and strokes, and boost overall survival rates. These findings were shared at ASMBS2026, the annual scientific conference of the American Society for Metabolic and Bariatric Surgery. Researchers emphasize that these surgeries do more than just promote weight loss; they might also slow down the progression of serious chronic illnesses.
Chronic kidney disease (CKD) is an escalating global health issue. It occurs when the kidneys gradually lose their ability to function properly over time. The kidneys are crucial for removing waste, balancing fluids, regulating blood pressure, and supporting overall health. When the kidneys sustain severe damage, waste builds up in the body, which can lead to life-threatening conditions requiring dialysis or a kidney transplant.
Approximately one in seven adults in the U.S. has CKD, with high prevalence among individuals with obesity, diabetes, and hypertension. Excess weight stresses the body, increasing inflammation, worsening insulin resistance, elevating blood pressure, and forcing the kidneys to work harder. Over the years, this stress can cause permanent harm to the kidneys.
While weight loss is known to improve many health issues, recent research indicates that metabolic and bariatric surgeries—such as sleeve gastrectomy and Roux-en-Y gastric bypass—may offer especially significant benefits for kidney health. These surgeries alter the digestive system, helping patients eat less and absorb nutrients differently. Many undergo substantial weight loss afterward and see improvements in conditions like diabetes, high blood pressure, and cholesterol.
Researchers analyzed data from over 8,900 patients with obesity and CKD using the TriNetX Research Network, which gathers electronic health records from numerous hospitals. The study tracked patients from 2010 to 2020, comparing those who had weight-loss surgery with similar patients who did not, over a period of five years.
The results were remarkable. Patients who had bariatric surgery were considerably less likely to develop end-stage kidney disease—the most severe form of kidney failure. Only around 6% of surgery patients progressed to kidney failure compared to nearly 12% of those who didn’t have surgery. Additionally, fewer surgery patients needed dialysis, a complex and time-consuming treatment that filters blood when kidneys no longer function properly; only 4.1% of surgery patients required dialysis versus 9% of non-surgery patients.
The study also showed that individuals who underwent surgery were more than twice as likely to receive a kidney transplant, possibly because improved overall health made them better candidates for the procedure.
Beyond kidney health, the benefits extended to cardiovascular health—surgery patients experienced significantly fewer heart attacks and strokes, with the risk dropping from nearly 28% among those without surgery to about 16% among surgical patients. Survival rates were also much better, with only 5% mortality among surgery recipients compared to 16% in non-surgical patients.
Dr. Jerry Dang from Cleveland Clinic Lerner College of Medicine, lead researcher of the study, stated that bariatric surgery appears to alter the entire disease course of CKD. Early intervention may slow kidney damage, improve heart health, reduce the progression to kidney failure, and increase chances for transplant.
Experts note that these positive outcomes are expected since weight-loss surgeries influence multiple bodily systems. They help control blood sugar, lower blood pressure, reduce inflammation, and boost metabolism—all factors that help protect the kidneys and blood vessels from long-term damage. Dr. Richard M. Peterson, president of ASMBS, praised the findings, describing the survival benefits as extraordinary. He highlighted that these procedures can preserve vital organ function and save lives, beyond just physical weight reduction.
This research might encourage physicians to consider bariatric surgery sooner for patients with obesity and CKD. Historically, such surgeries were viewed as a last resort for extreme obesity; however, many now see them as a vital treatment for obesity-related chronic diseases.
Nevertheless, experts caution that surgery is not a one-size-fits-all solution. It involves risks and requires ongoing lifestyle adjustments, medical follow-up, and nutritional monitoring. Patients must maintain healthy eating and regular physical activity to sustain the benefits long-term.
The study has limitations, as it relied on real-world medical records rather than randomized clinical trials, so it cannot definitively establish that surgery alone caused all the observed improvements—other factors might have influenced the results. Still, the large sample size and consistent health improvements make these findings highly significant.
Overall, this research adds to the growing evidence that treating obesity can prevent serious complications beyond weight issues. For those with obesity and CKD, early intervention might lead to fewer health problems, less dependence on dialysis, better heart health, and a higher chance of survival.
For further reading, explore studies linking pesticide exposure to CKD, medications that could prevent kidney failure in diabetics, or dietary choices—such as certain vegetables—that may protect kidney health.
All these insights were presented at the ASMBS2026 annual gathering. The study was conducted by researchers at Cleveland Clinic’s Lerner College of Medicine affiliated with Case Western Reserve University.
ChatGPT
Perplexity
Gemini AI
Grok AI
